Dr. Nathaniel Jenkins, PhD

Claim this profile
Studies Psychological Trauma
Studies Saccular Aneurysm
1 reported clinical trial
1 drug studied

Clinical Trials Nathaniel Jenkins, PhD is currently running

Image of trial facility.

Cognitive Behavioral Therapy

for Sleep Issues from Adverse Childhood Experiences

The overall purpose of this study is to understand the role of disrupted sleep in the association of exposure to early life adversity (adverse childhood experiences (ACEs)) with vascular endothelial (dys)function. In Aim 1 (The Iowa ACEs and Sleep Cohort Study), the investigators will utilize a cross-sectional cohort design with a state-of-the-art translational approach. Participants will be recruited to objectively characterize the degree to which lower sleep quality and quantity contribute to ACEs-related endothelial dysfunction, inflammation, and oxidative stress in young adults using: 1. rigorous at home sleep monitoring using 7-nights of wrist actigraphy and 2 nights of home-based polysomnography to objectively measure sleep quality (sleep efficiency, wakefulness after sleep onset and sleep depth), and total sleep duration, 2. in vivo assessment of endothelial function via flow-mediated dilation testing, and 3. in vitro determination of endothelial cell inflammation and oxidative stress from biopsied endothelial cells. This study to achieve this Aim. In Aim 2, approximately 70 eligible participants from Aim 1 (The Iowa ACEs and Sleep Cohort Study) will then be randomized to either a 6-week behavioral sleep intervention (cognitive behavioral therapy for insomnia) or a wait-list control to determine the mechanistic contribution of sleep disruption to vascular dysfunction in young adults with moderate-to-high exposure to adverse childhood experiences (ACEs). Following the intervention, participants will again complete: 1. rigorous at home sleep monitoring using 7-nights of wrist actigraphy and 2 nights of home-based polysomnography to objectively measure sleep quality (sleep efficiency, wakefulness after sleep onset and sleep depth), and total sleep duration, 2. in vivo assessment of endothelial function via flow-mediated dilation testing, and 3. in vitro determination of endothelial cell inflammation and oxidative stress from biopsied endothelial cells.
Recruiting1 award N/A1 criteria

More about Nathaniel Jenkins, PhD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Nathaniel Jenkins, PhD has experience with
  • Cognitive Behavioral Therapy For Insomnia (CBT-i)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nathaniel Jenkins, PhD specialize in?
Nathaniel Jenkins, PhD focuses on Psychological Trauma and Saccular Aneurysm. In particular, much of their work with Psychological Trauma has involved treating patients, or patients who are undergoing treatment.
Is Nathaniel Jenkins, PhD currently recruiting for clinical trials?
Yes, Nathaniel Jenkins, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Nathaniel Jenkins, PhD has studied deeply?
Yes, Nathaniel Jenkins, PhD has studied treatments such as Cognitive Behavioral Therapy for Insomnia (CBT-i).
What is the best way to schedule an appointment with Nathaniel Jenkins, PhD?
Apply for one of the trials that Nathaniel Jenkins, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.